|
CCNT1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.67564999999925E-05 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.778400E-02 |
| Normal-vs-Stage2 |
3.800300E-02 |
| Normal-vs-Stage3 |
9.68920000010698E-07 |
| Normal-vs-Stage4 |
1.41859999969185E-07 |
| Stage1-vs-Stage2 |
4.538200E-01 |
| Stage1-vs-Stage3 |
1.901930E-03 |
| Stage1-vs-Stage4 |
3.586600E-04 |
| Stage2-vs-Stage3 |
1.453030E-01 |
| Stage2-vs-Stage4 |
4.149700E-02 |
| Stage3-vs-Stage4 |
4.271000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.51730000000195E-05 |
| Normal-vs-AfricanAmerican |
3.80300000002443E-06 |
| Normal-vs-Asian |
5.521800E-01 |
| Caucasian-vs-AfricanAmerican |
2.436200E-02 |
| Caucasian-vs-Asian |
1.144210E-01 |
| AfricanAmerican-vs-Asian |
1.342320E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.87221999999876E-05 |
| Normal-vs-Female |
9.579500E-04 |
| Male-vs-Female |
4.907000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.343400E-03 |
| Normal-vs-Age(41-60Yrs) |
1.895250E-03 |
| Normal-vs-Age(61-80Yrs) |
2.41199999999608E-05 |
| Normal-vs-Age(81-100Yrs) |
3.079600E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.842970E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.030200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.619800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.562200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.832000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.859200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
9.868200E-01 |
| Normal-vs-Grade 2 |
1.922190E-02 |
| Normal-vs-Grade 3 |
1.56939999998995E-05 |
| Normal-vs-Grade 4 |
3.50140000326959E-08 |
| Grade 1-vs-Grade 2 |
4.227200E-01 |
| Grade 1-vs-Grade 3 |
1.109000E-01 |
| Grade 1-vs-Grade 4 |
9.481600E-03 |
| Grade 2-vs-Grade 3 |
2.732500E-02 |
| Grade 2-vs-Grade 4 |
1.421470E-04 |
| Grade 3-vs-Grade 4 |
2.515700E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
3.797800E-01 |
| Normal-vs-ccB subtype |
8.00640000000463E-05 |
| ccA subtype-vs-ccB subtype |
1.896950E-03 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.135070E-03 |
| Normal-vs-N1 |
2.107600E-01 |
| N0-vs-N1 |
6.577000E-01 |
|
|
